ABBV-383
A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-383 in Combination With Anti-Cancer Regimens for the Treatment of Adult Participants With Relapsed/Refractory Multiple Myeloma
Filters
Save & Share
Clear Filters
Location
Explore options near your patient - or anywhere in the US.
Diagnosis
Treatment History
BCMA Therapy
This stands for B Cell Maturation Antigen (BCMA) and includes treatments such as ide-cel, cilta-cel or belantamab mafodotin.
Near Add Your Location
Sorting 15 by
Memorial Sloan Kettering Cancer Center
New York, NY
- Accepting patients
University of Arkansas for Medical Sciences (UAMS)
Little Rock, AR
- Accepting patients
- Accepting patients
- Accepting patients
Valley Health System - Luckow Pavilion
Paramus, NJ
- Accepting patients
- Accepting patients
The University of Texas Southwestern Medical Center
Harold C. Simmons Comprehensive Cancer Center
Dallas, TX
- Accepting patients
- Accepting patients
- Accepting patients
University of Massachusetts Medical School
Worcester, MA
- Accepting patients
1,345 hidden based on your filters. Show All
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.